Journal
CARDIOVASCULAR RESEARCH
Volume 86, Issue 1, Pages 37-44Publisher
OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvp385
Keywords
Embryonic stem cells; Embryoid body; Leukotrienes; 5-Lipoxygenase; 5-Lipoxygenase activating protein
Categories
Funding
- 'Interdisziplinares Zentrum fur Klinische Forschung (IZKF) an der Medizinischen Fakultat der Friedrich-Schiller-Universitat Jena-Rotationsstellen fur r Assistenzarzte 2008-2009'
- 'Deutsche Stiftung Herzforschung' [F/08/07]
Ask authors/readers for more resources
It is well established that leukotrienes (LTs), products of the 5-lipoxygenase (5-LO) pathway, participate in inflammatory tissue reactions and immune responses. In the present study, the impact of the 5-LO pathway on vasculogenesis of mouse embryonic stem (ES) cells was investigated. Immunohistochemistry studies demonstrated that 5-LO(+) cells first appeared at day 6 of embryoid body (EB) formation from ES cells. 5-LO(+)/CD68(+) as well as 5-LO(+)/CD45(+) cells were prominent at day 10 of EB differentiation. Real-time PCR and western blot analysis revealed all constituents of the 5-LO pathway. High performance liquid chromatography analyses indicated the synthesis of LTB(4) and LTD(4) in conformity with induction of the 5-LO pathway. Furthermore, Flk-1(+)/CD105(+) cells displayed calcium- (Ca(2+)) transients in response to LTB(4), whereas CD11b(+) cells responded to LTD(4). Treatment of EBs with LTB(4) and LTD(4) resulted in phosphorylation of the mitogen-activated protein kinase ERK1/2. Pharmacological inhibition of the 5-LO pathway and stable shRNA targeting of 5-LO-activating protein decreased capillary cell areas positive for PECAM-1. Our data demonstrate that the 5-LO pathway emerges early during ES cell differentiation into cells of the myeloid lineage and that LTs play an until now unrecognized role in vascular development of ES cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available